Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

382 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[How to improve the surgical trials quality in daily practice].
Laas E, Feron JG, Laki F, Fourchotte V, Osdoit M, Asselain B, Reyal F, Lecuru F. Laas E, et al. Among authors: asselain b. Bull Cancer. 2022 Oct;109(10):1059-1065. doi: 10.1016/j.bulcan.2022.04.013. Epub 2022 Aug 19. Bull Cancer. 2022. PMID: 35995611 Review. French.
Quality assurance in surgical trials: An improvement is needed.
Lecuru F, Osdoit M, Balaya V, Faron EL, Feron JG, Laki F, Fourchotte V, Reyal F, Asselain B. Lecuru F, et al. Among authors: asselain b. Gynecol Oncol. 2020 Jun;157(3):570-571. doi: 10.1016/j.ygyno.2020.04.042. Epub 2020 Apr 22. Gynecol Oncol. 2020. PMID: 32334828 No abstract available.
Digital phenotyping in young breast cancer patients treated with neoadjuvant chemotherapy (the NeoFit Trial): protocol for a national, multicenter single-arm trial.
Delrieu L, Hamy AS, Coussy F, Kassara A, Asselain B, Antero J, De Villèle P, Dumas E, Forstmann N, Guérin J, Hotton J, Jouannaud C, Milder M, Leopold A, Sedeaud A, Soibinet P, Toussaint JF, Vercamer V, Laas E, Reyal F. Delrieu L, et al. Among authors: asselain b. BMC Cancer. 2022 May 4;22(1):493. doi: 10.1186/s12885-022-09608-y. BMC Cancer. 2022. PMID: 35509030 Free PMC article.
Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma.
Reyal F, Hajage D, Savignoni A, Feron JG, Bollet MA, Kirova Y, Fourquet A, Pierga JY, Cottu P, Dieras V, Fourchotte V, Laki F, Alran S, Asselain B, Vincent-Salomon A, Sigal-Zafrani B, Sastre-Garau X. Reyal F, et al. Among authors: asselain b. PLoS One. 2013;8(3):e55901. doi: 10.1371/journal.pone.0055901. Epub 2013 Mar 19. PLoS One. 2013. PMID: 23526930 Free PMC article.
Reasons of not having breast reconstruction: a historical cohort of 1937 breast cancer patients undergoing mastectomy.
Héquet D, Zarca K, Dolbeault S, Couturaud B, Ngô C, Fourchotte V, De La Rochefordière A, Féron JG, Fitoussi A, Bélichard C, Reyal F, Laki F, Hajage D, Sigal B, Asselain B, Alran S; Institut Curie Breast Cancer Group, Roman Rouzier. Héquet D, et al. Among authors: asselain b. Springerplus. 2013 Jul 18;2:325. doi: 10.1186/2193-1801-2-325. eCollection 2013. Springerplus. 2013. PMID: 23961399 Free PMC article.
Pregnancy, fertility concerns and fertility preservation procedures in a national study of French breast cancer survivors.
Mangiardi-Veltin M, Sebbag C, Rousset-Jablonski C, Ray-Coquard I, Berkach C, Laot L, Wang Y, Abdennebi I, Labrosse J, Sautter C, Toussaint A, Sablone L, Laas E, Khallouch S, Coussy F, Santulli P, Chapron C, Bobrie A, Jacot W, Sella N, Dumas E, Sénéchal-Davin C, Espie M, Giacchetti S, Maitrot L, Plu-Bureau G, Coutant C, Guerin J, Asselain B, Fumoleau P, Rodrigues M, Decanter C, Mailliez A, Delrieu L, Lemoine A, Jouannaud C, Houdre D, Reyal F, Hamy AS; Seintinelles Research Network. Mangiardi-Veltin M, et al. Among authors: asselain b. Reprod Biomed Online. 2022 Jun;44(6):1031-1044. doi: 10.1016/j.rbmo.2021.12.019. Epub 2022 Jan 19. Reprod Biomed Online. 2022. PMID: 35525718
Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome.
This P, de la Rochefordière A, Savignoni A, Falcou MC, Tardivon A, Thibault F, Alran S, Fourchotte V, Fitoussi A, Couturaud B, Dolbeault S, Salmon RJ, Sigal-Zafrani B, Asselain B, Stoppa-Lyonnet D; Institut Curie Breast and Ovarian Cancer Risk Study Group. This P, et al. Among authors: asselain b. Fam Cancer. 2012 Sep;11(3):473-82. doi: 10.1007/s10689-012-9539-1. Fam Cancer. 2012. PMID: 22711610 Clinical Trial.
Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer.
Hamy AS, Derosa L, Valdelièvre C, Yonekura S, Opolon P, Priour M, Guerin J, Pierga JY, Asselain B, De Croze D, Pinheiro A, Lae M, Talagrand LS, Laas E, Darrigues L, Grandal B, Marangoni E, Montaudon E, Kroemer G, Zitvogel L, Reyal F. Hamy AS, et al. Among authors: asselain b. Oncoimmunology. 2019 Nov 14;9(1):1677427. doi: 10.1080/2162402X.2019.1677427. eCollection 2020. Oncoimmunology. 2019. PMID: 32002287 Free PMC article.
Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial.
Hamy AS, Tury S, Wang X, Gao J, Pierga JY, Giacchetti S, Brain E, Pistilli B, Marty M, Espié M, Benchimol G, Laas E, Laé M, Asselain B, Aouchiche B, Edelman M, Reyal F. Hamy AS, et al. Among authors: asselain b. J Clin Oncol. 2019 Mar 10;37(8):624-635. doi: 10.1200/JCO.18.00636. Epub 2019 Jan 31. J Clin Oncol. 2019. PMID: 30702971 Free PMC article.
382 results